Hemoglobin E-beta-thalassemia syndrome

MONDO:0016491

Hemoglobin E - beta-thalassemia (HbE - BT) is a form of beta-thalassemia that results in a mild to severe clinical presentation ranging from a condition indistinguishable from beta-thalassemia major to a mild form of beta-thalassemia intermedia.

Also known as: E-beta-thalassemia, HbE-beta-thalassemia syndrome

27 clinical trials for this condition and its sub-types, 5 tagged with Hemoglobin E-beta-thalassemia syndrome itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Beta-thalassemia and related diseases (99)

Including sub-types (27) Tagged with Hemoglobin E-beta-thalassemia syndrome (5)

Trials to join now! 3 Not yet finished but already full! 1 Completed 1

New pill could cut blood transfusions for blood disorders

Disease control Completed

This Phase 2 study tested an experimental drug called etavopivat in 53 people with thalassemia or sickle cell disease. The goal was to see if the pill could safely reduce the number of red blood cell transfusions needed and raise hemoglobin levels. Participants took 400 mg of eta…

Phase 2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:04 UTC

Hemoglobin E-beta-thalassemia syndrome

Where it sits in the disease tree

New pill could cut blood transfusions for blood disorders